vTv Therapeutics (VTVT) Shares Outstanding (2014 - 2026)

vTv Therapeutics has disclosed Shares Outstanding (Entity) across 13 years of filings, most recently posting $12.4 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 88.39% year-over-year to $12.4 million; the TTM figure through Jun 2026 stood at $12.4 million (up 88.39% YoY), while the FY2025 annual figure was $8.4 million, up 45.96% from the prior year.
• Shares Outstanding (Entity) came in at $12.4 million for Q2 2026 at vTv Therapeutics, roughly flat from $12.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $12.4 million in Q2 2026 to a low of $2.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $5.4 million, with a median of $4.8 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) changed 0.0% in 2023 and surged 144.93% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $2.6 million in 2022, then rose by 1.83% to $2.7 million in 2023, then soared by 116.77% to $5.8 million in 2024, then surged by 45.96% to $8.4 million in 2025, then jumped by 47.32% to $12.4 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $12.4 million in Q2 2026, $12.4 million in Q1 2026, and $8.4 million in Q4 2025.